Community Research and Development Information Service - CORDIS

Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy

From 2016-08-01 to 2018-07-31, ongoing project

Project details

Total cost:

EUR 2 136 357,50

EU contribution:

EUR 2 136 357,50

Coordinated in:

Sweden

Call for proposal:

H2020-SMEINST-2-2016-2017See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

CLINICAL LASERTHERMIA SYSTEMS AB
Sweden

EU contribution: EUR 2 136 357,50


SCHEELEVAGEN 2 MEDICON VILLAGE
223 81 LUND
Sweden
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top